Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.
Identifieur interne : 001060 ( PubMed/Corpus ); précédent : 001059; suivant : 001061Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.
Auteurs : Sibel Eyigör ; Ece Cinar ; Ismail Caramat ; Burcu Koc UnluSource :
- Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [ 1433-7339 ] ; 2015.
English descriptors
- KwdEn :
- Adult, Aged, Antineoplastic Agents, Hormonal (therapeutic use), Arm (physiopathology), Breast Neoplasms (complications), Breast Neoplasms (drug therapy), Breast Neoplasms (physiopathology), Female, Humans, Lymphedema (complications), Lymphedema (drug therapy), Lymphedema (physiopathology), Middle Aged, Postoperative Period, Retrospective Studies, Tamoxifen (therapeutic use).
- MESH :
- chemical , therapeutic use : Antineoplastic Agents, Hormonal, Tamoxifen.
- complications : Breast Neoplasms, Lymphedema.
- drug therapy : Breast Neoplasms, Lymphedema.
- physiopathology : Arm, Breast Neoplasms, Lymphedema.
- Adult, Aged, Female, Humans, Middle Aged, Postoperative Period, Retrospective Studies.
Abstract
In clinical practice, noticeable differences are seen in patient response to the treatment of breast cancer-related lymphedema. Although some factors influencing response to treatment are mentioned in the literature, there is no sufficient evidence and results are confusing. For this reason, our objective in this study is to identify predictive and response-related factors for response to treatment of breast cancer-related lymphedema.
DOI: 10.1007/s00520-015-2633-9
PubMed: 25663541
Links to Exploration step
pubmed:25663541Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.</title><author><name sortKey="Eyigor, Sibel" sort="Eyigor, Sibel" uniqKey="Eyigor S" first="Sibel" last="Eyigör">Sibel Eyigör</name><affiliation><nlm:affiliation>Faculty of Medicine Physical Therapy and Rehabilitation Department, Tulay Aktas Oncology Hospital, Supportive Care Unit, Ege University, Bornova, 35100, Izmir, Turkey, eyigor@hotmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Cinar, Ece" sort="Cinar, Ece" uniqKey="Cinar E" first="Ece" last="Cinar">Ece Cinar</name></author><author><name sortKey="Caramat, Ismail" sort="Caramat, Ismail" uniqKey="Caramat I" first="Ismail" last="Caramat">Ismail Caramat</name></author><author><name sortKey="Unlu, Burcu Koc" sort="Unlu, Burcu Koc" uniqKey="Unlu B" first="Burcu Koc" last="Unlu">Burcu Koc Unlu</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25663541</idno><idno type="pmid">25663541</idno><idno type="doi">10.1007/s00520-015-2633-9</idno><idno type="wicri:Area/PubMed/Corpus">001060</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001060</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.</title><author><name sortKey="Eyigor, Sibel" sort="Eyigor, Sibel" uniqKey="Eyigor S" first="Sibel" last="Eyigör">Sibel Eyigör</name><affiliation><nlm:affiliation>Faculty of Medicine Physical Therapy and Rehabilitation Department, Tulay Aktas Oncology Hospital, Supportive Care Unit, Ege University, Bornova, 35100, Izmir, Turkey, eyigor@hotmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Cinar, Ece" sort="Cinar, Ece" uniqKey="Cinar E" first="Ece" last="Cinar">Ece Cinar</name></author><author><name sortKey="Caramat, Ismail" sort="Caramat, Ismail" uniqKey="Caramat I" first="Ismail" last="Caramat">Ismail Caramat</name></author><author><name sortKey="Unlu, Burcu Koc" sort="Unlu, Burcu Koc" uniqKey="Unlu B" first="Burcu Koc" last="Unlu">Burcu Koc Unlu</name></author></analytic><series><title level="j">Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</title><idno type="eISSN">1433-7339</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antineoplastic Agents, Hormonal (therapeutic use)</term><term>Arm (physiopathology)</term><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (physiopathology)</term><term>Female</term><term>Humans</term><term>Lymphedema (complications)</term><term>Lymphedema (drug therapy)</term><term>Lymphedema (physiopathology)</term><term>Middle Aged</term><term>Postoperative Period</term><term>Retrospective Studies</term><term>Tamoxifen (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents, Hormonal</term><term>Tamoxifen</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Arm</term><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Postoperative Period</term><term>Retrospective Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In clinical practice, noticeable differences are seen in patient response to the treatment of breast cancer-related lymphedema. Although some factors influencing response to treatment are mentioned in the literature, there is no sufficient evidence and results are confusing. For this reason, our objective in this study is to identify predictive and response-related factors for response to treatment of breast cancer-related lymphedema.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25663541</PMID><DateCreated><Year>2015</Year><Month>07</Month><Day>30</Day></DateCreated><DateCompleted><Year>2016</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2015</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-7339</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</Title><ISOAbbreviation>Support Care Cancer</ISOAbbreviation></Journal><ArticleTitle>Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.</ArticleTitle><Pagination><MedlinePgn>2705-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00520-015-2633-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">In clinical practice, noticeable differences are seen in patient response to the treatment of breast cancer-related lymphedema. Although some factors influencing response to treatment are mentioned in the literature, there is no sufficient evidence and results are confusing. For this reason, our objective in this study is to identify predictive and response-related factors for response to treatment of breast cancer-related lymphedema.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed data retrospectively from the files of patients with breast cancer-related lymphedema between 2006 and 2012. Patient demographics, clinical variables, and patient variables were recorded. Circumference measurements of lymphedema and healthy arms were recorded. We used a computer program (Limb Volumes Professional version 5.0) to transform these values to limb volumes in milliliters.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The average age of 331 patients was 54.4 ± 10.9. The average length of lymphedema treatment was 2.92 ± 1.3 weeks. A statistically significant positive correlation was found between postoperative weight gain and postoperative duration, number of chemotherapy (CT) cycles, duration of tamoxifen use, and duration of hormonal therapy (p < 0.05). There was a statistically significant negative correlation between posttreatment arm volume and activity level, postoperative duration, and postoperative weight gain (p < 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The treatment methods used for treating breast cancer had no effect on the response to treatment of lymphedema. Weight gain during the treatment of breast cancer is important for both the development of lymphedema and the response to treatment. When treating breast cancer-related lymphedema, the relationship between activity level and postoperative weight gain may provide us guidance in clinical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eyigör</LastName><ForeName>Sibel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Physical Therapy and Rehabilitation Department, Tulay Aktas Oncology Hospital, Supportive Care Unit, Ege University, Bornova, 35100, Izmir, Turkey, eyigor@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinar</LastName><ForeName>Ece</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Caramat</LastName><ForeName>Ismail</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Unlu</LastName><ForeName>Burcu Koc</ForeName><Initials>BK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Support Care Cancer</MedlineTA><NlmUniqueID>9302957</NlmUniqueID><ISSNLinking>0941-4355</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>094ZI81Y45</RegistryNumber><NameOfSubstance UI="D013629">Tamoxifen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018931" MajorTopicYN="N">Antineoplastic Agents, Hormonal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013629" MajorTopicYN="N">Tamoxifen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>05</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25663541</ArticleId><ArticleId IdType="doi">10.1007/s00520-015-2633-9</ArticleId><ArticleId IdType="pii">10.1007/s00520-015-2633-9</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001060 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001060 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:25663541
|texte= Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25663541" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |